There is a new paper about GSK3 and cardiac muscle: Cross-talk between glycogen synthase kinase β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle. Dionyssiou MG, Nowacki NB, Hashemi S, Zhao J, Kerr A, Tsushima R, McDermott JC.
This is an intereasting paper and they citated our paper abou Lithium and Alzheimer´s disease.
Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer�s disease.
Both are in Pubmed.

Lithium and GSK-3 beta enzyme

We published an article in Current Alzheimer Research about treating Alzheimer´s Disease with Lithium Microdose. Look at http://www.ncbi.nlm.nih.gov/pubmed/22746245. I want to talk with other researchers about Lithium and GSK-3beta enzyme.